Member of the Association of American Physicians
His primary scientific interests are in Internal medicine, Cancer, Oncology, Cancer research and Surgery. His research in Internal medicine intersects with topics in Gastroenterology and Gynecology. The various areas that he examines in his Cancer study include PI3K/AKT/mTOR pathway, Disease, Pathology and Immunology.
He works mostly in the field of Oncology, limiting it down to concerns involving Head and neck cancer and, occasionally, Primary tumor. His Cancer research research integrates issues from Carcinogenesis, Receptor, Oncogene and Cancer cell. His Surgery research is multidisciplinary, relying on both Incidence, Epidermoid carcinoma, Leukoplakia and Hazard ratio.
Scott M. Lippman mainly investigates Internal medicine, Oncology, Cancer, Cancer research and Pathology. His Internal medicine research incorporates themes from Gastroenterology and Surgery. The concepts of his Surgery study are interwoven with issues in Placebo and Epidermoid carcinoma.
His work carried out in the field of Oncology brings together such families of science as Clinical trial, Head and neck cancer, Gynecology, Breast cancer and Single-nucleotide polymorphism. Scott M. Lippman interconnects Carcinoma, Disease and Immunology in the investigation of issues within Cancer. His Cancer research study incorporates themes from Retinoid, Retinoic acid, Endocrinology, Cancer cell and Apoptosis.
Scott M. Lippman mostly deals with Internal medicine, Oncology, Cancer, Cancer research and Lung cancer. Scott M. Lippman frequently studies issues relating to Placebo and Internal medicine. As a part of the same scientific family, Scott M. Lippman mostly works in the field of Oncology, focusing on KRAS and, on occasion, Concordance.
His Cancer research includes themes of Precision medicine and Pathology. His research on Cancer research also deals with topics like
Scott M. Lippman focuses on Cancer, Internal medicine, Cancer research, Oncology and Lung cancer. He has included themes like Precision medicine and Gerontology in his Cancer study. His work focuses on many connections between Internal medicine and other disciplines, such as Surgery, that overlap with his field of interest in Placebo.
The Cancer research study combines topics in areas such as Salivary duct carcinoma, Malignancy, Gene knockdown, FAT1 and CDKN2A. Scott M. Lippman has researched Oncology in several fields, including Epidermal growth factor receptor, Survival rate, Mutation, Blockade and Prospective cohort study. The study incorporates disciplines such as Immunology, Tamoxifen, KRAS, Targeted therapy and Primary tumor in addition to Lung cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Influence of Finasteride on the Development of Prostate Cancer
Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia.
The New England Journal of Medicine (2003)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen.
The New England Journal of Medicine (2004)
Molecular origins of cancer: Lung cancer
Roy S. Herbst;John V. Heymach;Scott M. Lippman;Scott M. Lippman.
The New England Journal of Medicine (2008)
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia.
Head and neck cancer.
Everett E. Vokes;Ralph R. Weichselbaum;Scott M. Lippman;Waun Ki Hong.
The New England Journal of Medicine (1993)
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;D. Lawrence Wickerham;Walter M. Cronin.
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
Waun ki Hong;Scott M. Lippman;Loretta M. Itri;Daniel D. Karp.
The New England Journal of Medicine (1990)
Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley.
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Edward S. Kim;Vera Hirsh;Tony Mok;Mark A. Socinski.
The Lancet (2008)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: